Protara Therapeutics (TARA) Amortization - Intangibles (2022 - 2026)
Protara Therapeutics (TARA) recorded quarterly Amortization - Intangibles of $183000.0 in Q1 2026, down 42.09% quarter-over-quarter from $316000.0 in Q4 2025, and up 10.24% on a YoY basis from $166000.0 in Q1 2025.
Protara Therapeutics (TARA) Amortization - Intangibles (2022 - 2026) Analysis & Trends
Protara Therapeutics' Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $183000.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 10.24% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 46.09% YoY), while the FY2025 annual figure was $1.3 million, up 61.68% from the prior year.
- Amortization - Intangibles was $183000.0 for Q1 2026 at Protara Therapeutics, down from $316000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $444000.0 in Q3 2024 to a low of -$346000.0 in Q2 2022.
- Historically, Amortization - Intangibles has averaged $126687.5 across 5 years, with a median of $130000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles sank 94.7% in 2024, then jumped 5457.14% in 2025.
- A 5-year view of Amortization - Intangibles shows it stood at -$107000.0 in 2022, then jumped by 204.67% to $112000.0 in 2023, then soared by 158.93% to $290000.0 in 2024, then rose by 8.97% to $316000.0 in 2025, then sank by 42.09% to $183000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $183000.0 (Q1 2026), $316000.0 (Q4 2025), and $437000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | 316,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 389,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Sep 30, 2024 | 444,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 112,000.00 |
| Sep 30, 2023 | 128,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | -107,000.00 |
| Sep 30, 2022 | -274,000.00 |
| Jun 30, 2022 | -346,000.00 |